youtube_live
Q2 2027 earnings • in 1 day
See detailschevron_right
MCK:NYSE
McKesson Corp
$998.38
0.00%
(0.00) 1D
Nov 2, 4:00:03 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MCK...
Mkt. cap
116.40B
Avg. vol.
696.25K
Volume
5.58K
Dividend
0.38%
Quarterly dividend
$0.94
Ex-dividend date
Sep 1, 2026
P/E ratio
26.73
52-wk high
$1,030.27
52-wk low
$723.68
EPS
$37.35
Beta
0.27
Shares outstanding
116.59M
No. of employees
42K
Mkt. cap
116.40B
Avg. vol.
696.25K
Volume
5.58K
Dividend
0.38%
Quarterly dividend
$0.94
Ex-dividend date
Sep 1, 2026
P/E ratio
26.73
52-wk high
$1,030.27
52-wk low
$723.68
EPS
$37.35
Beta
0.27
Shares outstanding
116.59M
No. of employees
42K
News stories
From web sources and news partners
Yahoo Finance
·
23 hours ago
McKesson (MCK) Surged 13% Following Strong Q3 Results
Profile
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
About McKesson Corp
CEOBrian S. Tyler
Employees42.3K
Founded1835
Headquarters-
SectorHealth care provider
Websitemckesson.com
Analyst ratings
Based on 15 analysts giving stock ratings to MCK in the past 3 months
Strong buy
Buy
12
Hold
3
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for MCK in the last 3 months.
Highest
Current $998.38
$1,207.00 (+20.90%)
Average
$1,021.50 (+2.32%)
Lowest
$845.00 (-15.36%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Erin Wright Morgan Stanley | Buy | Reiterated | $1,207.00 | +20.9% | 10/30/2026 |
Steven Valiquette Mizuho Securities | Hold | Maintained | $1,020.00 | +2.2% | 10/20/2026 |
Kevin Caliendo UBS | Buy | Maintained | $1,200.00 | +20.2% | 10/16/2026 |
Unknown Analyst Leerink Partners | Buy | Maintained | $1,070.00 | +7.2% | 10/07/2026 |
Ryan Halsted RBC Capital | Hold | Maintained | $845.00 | -15.4% | 10/06/2026 |
Elizabeth Anderson CFA Evercore ISI | Buy | Maintained | $1,000.00 | +0.2% | 10/06/2026 |
George Hill Deutsche Bank | Buy | Maintained | $913.00 | -8.6% | 10/06/2026 |
Allen Lutz Bank of America Securities | Buy | Maintained | $1,050.00 | +5.2% | 10/05/2026 |
Ryan Daniels William Blair | Buy | Maintained | - | - | 10/05/2026 |
Glen Santangelo Barclays | Buy | Maintained | $1,000.00 | +0.2% | 08/18/2026 |
Lisa Gill J.P. Morgan | Buy | Maintained | $1,042.00 | +4.4% | 08/10/2026 |
Stephen Baxter Wells Fargo | Hold | Reiterated | $933.00 | -6.5% | 08/11/2026 |
Daniel Grosslight Citi | Buy | Reiterated | $1,000.00 | +0.2% | 08/10/2026 |
Eric Coldwell Robert W. Baird | Buy | Maintained | $1,015.00 | +1.7% | 08/06/2026 |
Charles Rhyee TD Cowen | Buy | Reiterated | $1,006.00 | +0.8% | 08/06/2026 |
Max Smock William Blair | Buy | Reiterated | - | - | 05/08/2026 |
Next call in 31:14:57
Wed, Nov 4, 4:30 PM
Fiscal period
Q2 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $10.75
Revenue / Est. (USD)
- / 109.95B
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 103.15B | 106.16B | 96.30B | 105.38B |
Cost of goods sold | 99.61B | 102.49B | 92.25B | 101.70B |
Cost of revenue | 99.61B | 102.49B | 92.25B | 101.70B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.12B | 2.03B | 1.92B | 2.26B |
Operating expense | 2.12B | 2.03B | 1.92B | 2.26B |
Total operating expenses | 101.73B | 104.52B | 94.17B | 103.96B |
Operating income | 1.42B | 1.64B | 2.13B | 1.42B |
Other non operating income | 62.00M | 74.00M | -156.00M | 66.00M |
EBT including unusual items | 1.40B | 1.63B | 2.12B | 1.31B |
EBT excluding unusual items | 1.40B | 1.65B | 2.10B | 1.41B |
Income tax expense | 232.00M | 380.00M | 270.00M | 276.00M |
Effective tax rate | 16.63% | 23.31% | 12.71% | 21.10% |
Other operating expenses | - | - | - | - |
Net income | 1.11B | 1.19B | 1.68B | 614.00M |
Net profit margin | 1.08% | 1.12% | 1.75% | 0.58% |
Earnings per share | 9.86 | 9.34 | 11.69 | 9.93 |
Interest and investment income | - | - | 179.00M | - |
Interest expense | -74.00M | -63.00M | -61.00M | -77.00M |
Net interest expenses | -74.00M | -63.00M | 118.00M | -77.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.60B | 1.83B | 2.19B | 1.62B |
Gain or loss from assets sale | -102.00M | - | -488.00M | -6.00M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events